Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 710

1.

Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.

Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J.

Can J Cardiol. 1997 Oct;13(10):914-20. Review.

PMID:
9374947
2.

Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.

Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.

Curr Med Res Opin. 2003;19(3):226-37.

PMID:
12803737
3.
4.

Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.

Mounier-Vehier C, Bernaud C, Carré A, Lequeuche B, Hotton JM, Charpentier JC.

Am J Hypertens. 1998 Apr;11(4 Pt 1):478-86.

PMID:
9607387
5.
7.

Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.

Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS; Korean Multicenter Amlodipine Study Investigators.

Clin Ther. 2007 Sep;29(9):1924-36.

PMID:
18035192
8.
9.

Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.

Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carré A.

Am J Hypertens. 2000 Feb;13(2):184-90.

PMID:
10701819
10.

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.

Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.

Clin Ther. 2004 Sep;26(9):1436-45.

PMID:
15531006
11.
14.

24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.

Ruddy TD, Wright JM, Savard D, Handa SP, Chockalingam A, Fischer L, Boulet AP.

Cardiovasc Drugs Ther. 1995 Dec;9(6):799-807.

PMID:
8850385
15.

Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.

Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelant S.

J Hypertens. 1996 Jan;14(1):137-44.

PMID:
12013487
16.

Comparison of amlodipine and long-acting diltiazem in the treatment of mild or moderate hypertension.

Horwitz LD, Weinberger HD, Clegg L.

Am J Hypertens. 1997 Nov;10(11):1263-9.

PMID:
9397246
17.
20.

Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.

de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.

J Hypertens. 1998 Nov;16(11):1357-69.

PMID:
9856375
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk